Gain-of-function mutations in CTLA4 and PTNP22 are observed in thymoma-associated MG (96, 97), likely leading to a loss of negative selection and suggesting common pathophysiological pathways with late-onset MG. This evidence concerns the gene CTLA4 and myasthenia gravis.